CHPA Welcomes New Members to Board of Directors, Executive Committee

Washington, D.C. – The Consumer Healthcare Products Association (CHPA) announced the election of two new members to the CHPA Board of Directors and two new members to the CHPA Executive Committee today during the association’s June board meeting.

Steven R. LaMonte, chairman of the board, Fleet Laboratories, and Ronald M. Lombardi, president and CEO, Prestige Brands Holdings, Inc., will serve on the CHPA Board of Directors.

Current board members elected to the CHPA Executive Committee are Denice Torres, president, McNeil Consumer Healthcare, Johnson & Johnson, and Michael J. Donnantuono, president and chief operating officer, Blistex Inc.

“CHPA is excited to welcome new members to our board and our executive committee, and we look forward to benefitting from their involvement and perspective they will bring as we navigate an exciting time for consumer healthcare,” CHPA President and CEO Scott Melville said. “As we continue to carry out CHPA’s strategic priorities, we are fortunate to have board and executive committee members who represent the spectrum of consumer healthcare to ensure our association serves the needs and concerns of the industry as a whole.”

 #   #   #

The Consumer Healthcare Products Association (CHPA) is the 134-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.
http://chpa.org

Contact: Jenni Terry (202) 429-9260